C5a Receptor Antagonist, linear, human, rat - 1 mg
- Cat.Number : AS-65122
- Manufacturer Ref. :
-
Availability :
In production
Alternative choices
This linear peptide is derived from the C-terminus of the chemokine, complement fragment 5 anaphylatoxin (C5a). This peptide functions to inhibit C5a binding and function at human and rat C5a receptors. C5a is crucial to triggering cellular immune responses and its overexpression is involved in arthritis, Alzheimer’s disease, cystic fibrosis, systemic lupus erythematosus, and other immunoinflammatory diseases.
Specifications
Chemistry | |
Sequence one letter code |
|
---|---|
Sequence three letter code |
|
Molecular Mass/ Weight |
|
Modification | |
Conjugation |
|
Quantity & Purity | |
Purity |
|
Storage & stability | |
Form |
|
Storage Conditions |
|
Activity | |
Biomarker Target | |
Research Area | |
Sub-category Research Area | |
Usage |
|
Source | |
Source / Species |
|
Downloads
You may also be interested in the following product(s)
References
Comparative Agonist/Antagonist Responses in Mutant Human C5a Receptors Define the Ligand Binding Site
J Biol Chem . 2005 May 01 ; 280(18) 17831 | DOI : https://doi.org/10.1074/jbc.M410797200
- A. Higginbottom
- et al
Disulfide trapping to localize small-molecule agonists and antagonists for a G protein-coupled receptor
PNAS . 2005 Feb 22 ; 102(8) 2719 | DOI : https://doi.org/10.1073/pnas.0500016102
- E. Buck
- J. Wells